Weight Loss

What to Look for in a Protein Powder?

Besides a balanced diet, many individuals opt to include supplements as part of their daily food intake. Protein powder is one such supplement which has become increasingly popular over recent years, with many users who want to achieve weight loss and muscle growth.

Unexplained Weight Loss: When It Might Signal a Health Problem

Circadian Rhythm and Weight Loss

Wegovy: A Breakthrough in Weight Loss?

Mental Health Disorders, Weight Gain, and Exercise

How Does Semaglutide Work to Lose Weight?

Latest Weight Loss News and Research

GLP-1 discontinuation associated with more weight gain and pregnancy complications

In a study led by researchers at Mass General Brigham, pregnant individuals who stopped taking popular weight loss GLP-1 medications before or early in their pregnancy tended to gain more weight and have higher risks of diabetes and hypertensive disorders during pregnancy, and experienced preterm delivery more so than people who had never taken GLP-1 drugs.

24 Nov 2025

Vegan diet with unhealthy plant foods promotes greater weight loss than Mediterranean diet

Eating a vegan diet increases consumption of plant-based foods-including those defined as "unhealthy" by the plant-based diet index-leading to greater weight loss than the Mediterranean diet, finds a new analysis by the Physicians Committee for Responsible Medicine published in Frontiers in Nutrition.

24 Nov 2025

Gaining too little or too much weight in pregnancy affects birth outcomes

The review of 1.6 million pregnancies shows diverse weight gain impacts, stressing the urgency for updated guidelines to improve maternal and infant health.

24 Nov 2025

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Researchers showed that GLP-1 receptor agonism counteracts aging across multiple organs in mice, improving strength and reversing molecular aging signatures without meaningful effects on body weight. These benefits depended largely on hypothalamic GLP-1R signaling and closely mirrored the anti-aging patterns produced by rapamycin.

23 Nov 2025

Combined healthy eating and exercise linked to greater reductions in visceral fat

Improving diet and increasing physical activity levels together may be more effective at preventing weight gain – particularly harmful fat inside the abdomen – than just changing one of these behaviours, new research from the University of Cambridge suggests.

21 Nov 2025

Marine bacterium shows powerful therapeutic effects against colorectal cancer

A research team led by Professor Eijiro Miyako at the Graduate School of Advanced Science and Technology, Japan Advanced Institute of Science and Technology (JAIST), has discovered that the marine bacterium Photobacterium angustum demonstrates remarkable therapeutic efficacy against colorectal cancer.

21 Nov 2025

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings from the ATTAIN-2 trial led by a UTHealth Houston researcher.

20 Nov 2025

Searches for “Ozempic face” surge as people look for filler-based solutions

Public interest in “Ozempic face” rose sharply from 2022 to 2025, mirrored by increased searches for nonsurgical facial filler procedures. Surgical terms showed neutral or negative associations, indicating consumers are primarily exploring filler-based solutions for GLP-1RA-related facial volume loss.

20 Nov 2025

Study shows how ketogenic eating improves hormonal balance in PCOS

The very low-carbohydrate ketogenic diet leads to meaningful reductions in weight, visceral adiposity, insulin resistance, and androgen excess in women with PCOS based on pooled randomized trials. Benefits appear consistent across studies, though high heterogeneity, short durations, and limited safety data highlight the need for longer-term comparative research.

19 Nov 2025

Oral semaglutide delivers real-world drops in blood sugar and weight in diabetes trial

Oral semaglutide delivered meaningful reductions in HbA1c and body weight among GLP-1RA-naïve adults with type 2 diabetes in a Dutch real-world cohort. Lipid levels and blood pressure showed only small changes, reflecting modest cardiometabolic effects outside glucose and weight control.

18 Nov 2025

Brain recordings reveal short-lived effects of tirzepatide on food cravings

A rare glimpse into the brain activity of a patient with obesity and loss of control eating on tirzepatide, marketed as Mounjaro and Zepbound, revealed that the medication suppresses signaling in the brain's "reward center" thought to be involved in food noise – but only temporarily.

17 Nov 2025

Off-label GLP-1 use highlights the cultural pressures driving body anxieties

New obesity drugs that were designed to treat diabetes and obesity are increasingly being used off-label by people without these conditions to achieve slimness and social approval rather than health gains. This perspective maps how such pharmacological thinness interacts with stigma, beauty ideals, digital culture, and inequality, and calls for multinational, intersectional research to understand its full impact.

13 Nov 2025

What The Health? From KFF Health News: The government is open

The longest federal government shutdown in history is over, after a handful of House and Senate Democrats joined most Republicans in approving legislation that funds the government through January. Despite Democrats' demands, the package did not include an extension of the expanded tax credits that help most Affordable Care Act enrollees afford their plans — meaning most people with ACA plans are slated to pay much more toward their premiums next year.

13 Nov 2025

What diet do people with type 2 diabetes really want? Study reveals flexibility beats strict meal plans

A large UK survey of adults with type 2 diabetes found that most prefer flexible, food-based diets—particularly moderate calorie restriction or low-carbohydrate plans, over formula-based regimens. Preferences varied by age, lifestyle, and desired outcomes, underscoring the need for personalized dietary support.

11 Nov 2025

GLP-1 drugs linked to improved survival in colon cancer patients

A new University of California San Diego study offers compelling evidence that glucagon-like peptide-1 (GLP-1) receptor agonists - the class of drugs behind Ozempic, Wegovy and Mounjaro, for example - may do more than regulate blood sugar and weight.

11 Nov 2025

Nanoparticle vaccine eliminates HPV-induced tumors in animal model

A nanoparticle vaccine designed to fight cancers induced by human papillomavirus (HPV) eradicated tumors in an animal model of late-stage metastatic disease, UT Southwestern Medical Center scientists report in a new study published in the Proceedings of the National Academy of Sciences (PNAS).

11 Nov 2025

Metformin shows promise in treating AFib recurrence after ablation

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes medication metformin in addition to standard care, according to a preliminary, late-breaking science presentation today at the American Heart Association's Scientific Sessions 2025.

11 Nov 2025

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

In youth newly diagnosed with type 2 diabetes, GLP-1–based therapies, including semaglutide and tirzepatide, achieved similar blood sugar control but significantly greater reductions in body mass index than metformin. These findings highlight the potential of high-potency GLP-1 agents as effective monotherapy options in managing obesity and glycemic control in adolescents.

10 Nov 2025

Weill Cornell scientists discover early step in fat cell inflammation leading to diabetes

Weill Cornell Medicine investigators have identified an early step in a cellular process that leads to inflammation in fat cells and may result in type 2 diabetes in people with obesity.

10 Nov 2025

Weight loss drugs used by patients with high triglycerides do not increase pancreatitis risk

In a major new study, researchers from Intermountain Health in Salt Lake City have found that weight loss drugs used by patients who have high triglycerides do not increase their risk of pancreatitis or adverse cardiac events.

10 Nov 2025

Weight Loss

Overview

Unexplained Weight Loss: When It Might Signal a Health Problem

Circadian Rhythm and Weight Loss

Wegovy: A Breakthrough in Weight Loss?

Feature Articles

Mental Health Disorders, Weight Gain, and Exercise

How Does Semaglutide Work to Lose Weight?

Latest Weight Loss News and Research

GLP-1 discontinuation associated with more weight gain and pregnancy complications

Vegan diet with unhealthy plant foods promotes greater weight loss than Mediterranean diet

Gaining too little or too much weight in pregnancy affects birth outcomes

Study finds GLP-1 drugs improve strength and reverse aging biology in mice

Combined healthy eating and exercise linked to greater reductions in visceral fat

Marine bacterium shows powerful therapeutic effects against colorectal cancer

Oral GLP-1 pill shows strong weight loss and blood sugar benefits in adults with diabetes

Searches for “Ozempic face” surge as people look for filler-based solutions

Study shows how ketogenic eating improves hormonal balance in PCOS

Oral semaglutide delivers real-world drops in blood sugar and weight in diabetes trial

Brain recordings reveal short-lived effects of tirzepatide on food cravings

Off-label GLP-1 use highlights the cultural pressures driving body anxieties

What The Health? From KFF Health News: The government is open

What diet do people with type 2 diabetes really want? Study reveals flexibility beats strict meal plans

GLP-1 drugs linked to improved survival in colon cancer patients

Nanoparticle vaccine eliminates HPV-induced tumors in animal model

Metformin shows promise in treating AFib recurrence after ablation

GLP-1 drugs beat metformin for weight control in teens with type 2 diabetes

Weill Cornell scientists discover early step in fat cell inflammation leading to diabetes

Weight loss drugs used by patients with high triglycerides do not increase pancreatitis risk

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Weight Loss

Overview

Feature Articles

Mental Health Disorders, Weight Gain, and Exercise

How Does Semaglutide Work to Lose Weight?

Latest Weight Loss News and Research

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in